Ontamalimab
SHP647-306
Phase 3 mab terminated
Quick answer
Ontamalimab for Crohn's Disease is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Crohn's Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated